Drug-Eluting Balloon for the Treatment of Failing Hemodialytic Radiocephalic Arteriovenous Fistulas: Our Experience in the Treatment of Juxta-Anastomotic Stenoses

Patanè, Domenico; Giuffrida, Sergio; Morale, Walter; L'Anfusa, Giuseppe; Puliatti, D; Bisceglie, Paola; Seminara, Giuseppe; Calcara, Giacomo; Landro, Domenico Di; Malfa, Pierantonio

doi:10.5301/jva.5000211

Cited by 60 publications

(53 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Primary lesion patency was significantly better after PCB at 6 months but not at 1 year (70% vs 0% [P < .01] at 6 mo; 20% vs 0% [P > .05] at 1 y) (16). Patane et al (17) treated juxtaanastomotic stenosis of AVFs in a single-center, single-arm prospective study and reported a 1-year primary patency rate of 91% in 26 patients. To our knowledge, the only study that actually explored the use of PCB in CVS was a retrospective analysis by Massmann et al (26) in which central and peripheral veins in dialysis access circuits were treated.…”

Section: Discussionmentioning

confidence: 95%

“…Paclitaxel-coated balloons (PCBs) have been tested for their safety and efficacy in the treatment of dysfunctional dialysis access in a few randomized studies and retrospective analysis of cases, with encouraging results so far (14)(15)(16)(17)(18). In two randomized controlled trials that used PCBs in arteriovenous fistulae (AVFs) and the venous outflow of arteriovenous grafts (AVGs) (14,15), the use of PCBs demonstrated significantly better results than conventional angioplasty.…”

mentioning

confidence: 96%

See 1 more Smart Citation

Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial

Kitrou

Papadimatos

Spiliοpoulos

et al. 2017

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 95%

mentioning

confidence: 96%

Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial

Kitrou

Papadimatos

Spiliοpoulos

et al. 2017

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

“…Elastic or rigid stenoses can be treated by conventional PTA and stent implantation as well as by cutting balloon, for example [10,11]. To prevent recurrent stenoses, the use of drug-coated balloons is increasingly being reported [12,13]. There are currently no randomized studies or even larger case series showing a superior long-term patency rate for endovascular brachytherapy [14,15] and cryoplasty [16].…”

mentioning

confidence: 99%

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Kamper

Faizy²,

Haage³

2015

Fortschr Röntgenstr

View full text Add to dashboard Cite

A wide variety of diagnostic and minimally invasive modalities is currently available to radiologists for providing sufficient medical care for dialysis patients. In addition to clinical examination, ultrasound is the first line imaging method in suspected dialysis vascular access dysfunction. The percutaneous approach is the primarily recommended therapeutic option in many cases. This article reviews the current diagnostic and therapeutic methods in dialysis vascular access insufficiency. Key Points: ??Vascular access dysfunction is often elicited by stenosed vessels, which are regularly associated with concomitant thrombosis. ??Stenoses are commonly observed in the anastomosis, vascular access vein and also in the central venous system. ??Beside the clinical examination, sonography is the diagnostic method of first choice. ??Percutaneous balloon dilatation frequently is the first treatment option. Citation Format: ??Kamper L, Faizy TD, Haage P. Diagnosis and Treatment of Insufficient Dialysis Vascular Access. Fortschr R?ntgenstr 2015; 187: 360???371

show abstract

“…At 6 months, primary target lesion patency following angioplasty with PCB was reported in previous studies to range from 44 to 97%. These findings were higher than the 6‐month circuit patency of 42.9% of all accesses reported in our study.…”

Section: Discussionmentioning

confidence: 63%

Paclitaxel‐coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real‐world experience and longitudinal follow up

et al. 2019

View full text Add to dashboard Cite

Aim Dysfunctional arteriovenous (AV) access remains a significant cause of morbidity and hospital admission for patients with end stage renal failure on haemodialysis. This study was performed to evaluate the impact of paclitaxel‐coated Balloon (PCB) on the patency of AV access with recurrent stenoses. Methods We retrospectively studied haemodialysis patients who presented to our centre with recurrent AV access dysfunction and compared intervention‐free patency using plain balloon versus PCB. Results A total of 147 patients were followed up longitudinally. Intervention‐free patency was better following PCB compared to previous intervention using plain balloons (6.4 ± 5.8 versus 4.0 ± 3.7, P < 0.01). The 3‐ and 6‐month patency rates after PCB were significantly better compared to standard plain angioplasty balloon: 69.4% versus 52.4%, P < 0.01 and 42.9% versus 15.6%, P < 0.01 respectively. Kaplan–Meier survival analysis of circuit patency demonstrated the superiority of PCB over plain balloon angioplasty in both arteriovenous fistula and arteriovenous graft (P < 0.01 and P = 0.01 respectively) although the patency of arteriovenous fistula remained significantly better than arteriovenous graft following interventions with PCB (P < 0.01). Age of AV access and the number of previous interventions were found to be significant predictors of patency following PCB intervention. Conclusion Arteriovenous access intervention with PCB was shown to be superior compared to plain balloon in the treatment of both non‐thrombosed and thrombosed AV accesses in our multi‐ethnic population.

show abstract

Drug-Eluting Balloon for the Treatment of Failing Hemodialytic Radiocephalic Arteriovenous Fistulas: Our Experience in the Treatment of Juxta-Anastomotic Stenoses

Abstract: The use of drug-eluting balloons, after standard angioplasty, improves primary patency and decreases reinterventions of TL in juxta-anastomotic stenoses of failing native dialytic arteriovenous shunts.

Cited by 60 publications

References 53 publications

Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial

Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Paclitaxel‐coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real‐world experience and longitudinal follow up

Contact Info

Product

Resources

About